Ligand validation:4X81

MVI: Mycinamicin VI

MVI is a Ligand Of Interest in 4X81 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4X81_MVI_A_305	23%	75%	0.191	0.812	0.37	0.6	-	-	0	0	100%	1
4X81_MVI_B_305	19%	78%	0.201	0.795	0.37	0.53	-	-	0	0	100%	1
4X7W_MVI_B_303	17%	59%	0.206	0.78	0.63	0.95	1	2	2	0	100%	0.8
3SSN_MVI_A_701	45%	33%	0.206	0.94	1.33	1.32	5	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.